Hybrid operon for expression of colonization factor (CF) antigens of enterotoxigenic escherichia coli

Details for Australian Patent Application No. 2008270303 (hide)

Owner Crucell Sweden AB

Inventors Lebens, Michael; Svennerholm, AnnMari; Tobias, Joshua

Agent Davies Collison Cave

Pub. Number AU-A-2008270303

PCT Pub. Number WO2009/004002

Priority 07111501.8 02.07.07 EP

Filing date 1 July 2008

Wipo publication date 8 January 2009

International Classifications

C12N 15/70 (2006.01) Mutation or genetic engineering - Vectors or expression systems specially adapted for E. coli

A61K 39/02 (2006.01) Medicinal preparations containing antigens or antibodies - Bacterial antigens

Event Publications

24 December 2009 PCT application entered the National Phase

  PCT publication WO2009/004002 Priority application(s): WO2009/004002

3 November 2011 Assignment before Grant

  Crucell Sweden AB The application has been assigned to GOTOVAX AB

12 July 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008270313-Distribution of system information containing validity information for improved cell reselection

2008270300-Chemical compounds